DE68917972D1 - Pertussistoxoid-Impfstoff. - Google Patents

Pertussistoxoid-Impfstoff.

Info

Publication number
DE68917972D1
DE68917972D1 DE68917972T DE68917972T DE68917972D1 DE 68917972 D1 DE68917972 D1 DE 68917972D1 DE 68917972 T DE68917972 T DE 68917972T DE 68917972 T DE68917972 T DE 68917972T DE 68917972 D1 DE68917972 D1 DE 68917972D1
Authority
DE
Germany
Prior art keywords
pertussis toxoid
toxoid vaccine
vaccine
pertussis
whooping cough
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68917972T
Other languages
English (en)
Other versions
DE68917972T2 (de
Inventor
Larry K Winberry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MASSACHUSETTS HEALTH RES
Original Assignee
MASSACHUSETTS HEALTH RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MASSACHUSETTS HEALTH RES filed Critical MASSACHUSETTS HEALTH RES
Application granted granted Critical
Publication of DE68917972D1 publication Critical patent/DE68917972D1/de
Publication of DE68917972T2 publication Critical patent/DE68917972T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE68917972T 1988-04-20 1989-04-20 Pertussistoxoid-Impfstoff. Expired - Fee Related DE68917972T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18388488A 1988-04-20 1988-04-20

Publications (2)

Publication Number Publication Date
DE68917972D1 true DE68917972D1 (de) 1994-10-13
DE68917972T2 DE68917972T2 (de) 1995-01-05

Family

ID=22674711

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68917972T Expired - Fee Related DE68917972T2 (de) 1988-04-20 1989-04-20 Pertussistoxoid-Impfstoff.

Country Status (10)

Country Link
US (1) US5989564A (de)
EP (1) EP0338566B1 (de)
JP (1) JP2889923B2 (de)
AT (1) ATE110964T1 (de)
AU (1) AU631351B2 (de)
DE (1) DE68917972T2 (de)
DK (1) DK192489A (de)
ES (1) ES2059605T3 (de)
YU (1) YU47972B (de)
ZA (1) ZA892908B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE210452T1 (de) * 1992-10-02 2001-12-15 Alberta Res Council Entzündungshemmende tolerogene und immunoinhibitorische eigenschaften von karbohydrate bindende peptide
US5453272A (en) * 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
US5856122A (en) * 1993-08-24 1999-01-05 University Of Alberta Modification of pertussis toxin
WO2021001540A1 (en) 2019-07-04 2021-01-07 Proxi Biotech Aps Detoxification of proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions

Also Published As

Publication number Publication date
ATE110964T1 (de) 1994-09-15
JPH0272200A (ja) 1990-03-12
DE68917972T2 (de) 1995-01-05
ES2059605T3 (es) 1994-11-16
YU47972B (sh) 1996-08-13
YU80389A (en) 1992-05-28
US5989564A (en) 1999-11-23
DK192489A (da) 1989-10-21
AU631351B2 (en) 1992-11-26
AU3318289A (en) 1989-10-26
EP0338566A3 (en) 1990-08-22
JP2889923B2 (ja) 1999-05-10
EP0338566B1 (de) 1994-09-07
ZA892908B (en) 1990-04-25
DK192489D0 (da) 1989-04-20
EP0338566A2 (de) 1989-10-25

Similar Documents

Publication Publication Date Title
DK0625053T3 (da) Urease-baseret vaccine mod Helicobacter-infektion
DE122005000046I1 (de) Azellul{rer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enth{lt.
LU91595I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
NO1997010I1 (no) Bordetella pertussis P69 antigen
EP0269729A4 (de) Verfahren zur herstellung von toxoid.
FI99211B (fi) Menetelmä hirudiinivariantin valmistamiseksi
DE69113991T2 (de) Impfstoff.
DE68917972D1 (de) Pertussistoxoid-Impfstoff.
NO892997D0 (no) Bordetella pertussis vaksine.
CA2004206A1 (en) Method for preparing pertussis toxin toxoid
NZ236230A (en) Bordetella pertussis toxins genetically modified to remove toxicity but retain immunogenicity, vaccines
IL84276A0 (en) Vaccine against whooping cough
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee